US Stock Market Today, Nov. 24, 2025: Futures Rise on Fed Rate-Cut Hopes, Bitcoin Rebound and Novo Nordisk Shock Before the Opening Bell

As Wall Street wakes up on Monday, November 24, 2025, U.S. stock futures are pointing to a positive open for the Dow Jones, S&P 500 and Nasdaq, kicking off a holiday‑shortened Thanksgiving week. Gains are being driven by rising expectations of a December Federal Reserve rate cut, a rebound in bitcoin and crypto‑linked stocks, and heavy pre‑market trading in big tech and AI names — even as November remains one of the roughest months of the year for equities so far. ^[1]

At the same time, a failed Alzheimer’s trial from Novo Nordisk, renewed U.S.–EU trade tensions and cautious optimism around Ukraine peace talks are shaping sector‑specific moves in healthcare, defense, industrials and tech. ^[2]

Key things to know before the US market opens today (Nov. 24, 2025)

Futures are higher: Dow, S&P 500 and Nasdaq futures are up roughly 0.3% to 1% ahead of the open as rate‑cut bets rise and investors look for a rebound after a bruising November. ^[3]
Fed cut odds jump: Traders now put roughly a two‑thirds to three‑quarters chance on another Fed rate cut at the December 9–10 meeting after New York Fed President John Williams signaled there may be “room for a further adjustment.” ^[4]
Data calendar is distorted by the shutdown: No major U.S. data are due today, but delayed PPI and September retail sales, plus other reports later this week, will hit a market already dealing with canceled Q3 GDP estimates due to the recent government shutdown. ^[5]
Crypto is bouncing: Bitcoin has climbed back into the mid‑$80,000s after falling to its lowest level since April last week, lifting crypto‑sensitive names and ETFs. ^[6]
Novo Nordisk is under pressure: Shares of the Ozempic maker are down sharply pre‑market after a key Alzheimer’s trial failed to slow disease progression, a major storyline for healthcare and the GLP‑1 trade. ^[7]
Pre‑market most active: Leveraged Tesla ETF TSLL, Novo Nordisk (NVO), Alphabet (GOOGL), Nvidia (NVDA), crypto ETFs IBIT and ETHA, and EV maker NIO are among the busiest names before the bell. ^[8]

1. Futures point to a higher open in a battered November

U.S. stock futures are higher early Monday as traders try to extend a rebound from last week’s late‑week bounce:

E‑mini S&P 500 futures are up around 0.6%–0.7%.
Nasdaq‑100 futures are ahead by about 0.9%–1%.
Dow futures are gaining roughly 0.3%–0.4%, according to multiple pre‑market indicators. ^[9]

The move follows a volatile stretch marked by a sharp sell‑off in AI and growth stocks and rising concern about an “AI bubble.” Even after today’s positive tone, the major indexes remain down about 3%–6% for November, putting them on track for their worst month since March. ^[10]

Yet on a year‑to‑date basis, the rally is still impressive: the S&P 500 is up roughly 14%, the Dow about 9%, the Nasdaq around 18%, and the small‑cap Russell 2000 about 8% as of Friday’s close. ^[11]

This week’s trading will be shortened by the Thanksgiving holiday on Thursday, with U.S. markets closed that day and operating on a truncated schedule Friday — a factor that can exaggerate intraday moves as liquidity thins out. ^[12]

2. Fed rate‑cut hopes: the main driver of sentiment

The central story driving futures higher is the growing conviction that the Federal Reserve will deliver another rate cut in December.

New York Fed President John Williams said Friday there may be “room for a further adjustment” in policy, which investors interpreted as a green light for a near‑term cut. ^[13]
The Fed has already lowered its benchmark rate at each of the last two meetings (September and October) amid rising worries about labor‑market softness. ^[14]
Futures markets now assign roughly a 60–75% probability of a December cut, up from around 40% just days ago, according to Fed‑watching tools referenced in market commentary. ^[15]

But policymakers are not unanimous. Boston Fed President Susan Collins said over the weekend she is still leaning against a December cut, stressing that inflation risks remain. ^[16]

Data challenges after the shutdown

The rate debate is complicated by a distorted data calendar:

A government shutdown from October 1 to November 12 has delayed or disrupted several key releases. ^[17]
The U.S. Bureau of Economic Analysis (BEA) announced today it has canceled the advance estimate of Q3 GDP, which had originally been scheduled for October 30, and has pushed back the second estimate and preliminary corporate‑profit data as well. ^[18]
Some releases, including PPI and September retail sales, will now hit this week instead of earlier in the fall. ^[19]
Reuters notes that October and November payrolls data will only be released after the Fed meets in December, meaning policymakers will be “flying blinder” than usual. ^[20]

For markets, this mix — looser policy expectations but murkier data — is a recipe for heightened sensitivity to every Fed comment and to any number that does manage to make it onto the calendar.

3. Today’s economic calendar: quiet Monday, important week

If you’re looking for a blockbuster U.S. macro release today, you’ll be disappointed.

According to multiple economic‑calendar providers, no major U.S. economic reports are scheduled for Monday, November 24. ^[21]

Instead, the focus is on:

Tuesday (Nov. 25):
- Delayed Producer Price Index (PPI) for September
- Retail sales for September
- U.S. home‑price indices and Conference Board consumer confidence ^[22]
Wednesday (Nov. 26):
- Durable goods orders
- Weekly jobless claims
- U.S. crude‑inventory data ^[23]
Thursday: U.S. markets closed for Thanksgiving.
Friday: Chicago business sentiment and other regional indicators. ^[24]

One item that is on today’s radar: a large two‑year U.S. Treasury auction, alongside the regular 13‑ and 26‑week bill sales, giving an important read on demand for short‑dated government debt after a week of falling yields. ^[25]

If appetite for the 2‑year note is strong, it could reinforce the “rate‑cuts‑are‑coming” narrative. Weak demand, by contrast, might push yields higher and cool some of this morning’s equity optimism.

4. Crypto rebound lifts risk appetite – and pre‑market leaders

Bitcoin’s brutal pullback earlier this month — from highs near $125,000 in early October to around $81,000 late last week — rattled risk sentiment and hammered crypto‑linked names. ^[26]

But over the weekend and into Monday morning:

Bitcoin has rebounded into the mid‑$80,000s, up from last week’s lows and off the key $80,000 area that some traders see as a potential technical tripwire. ^[27]
Crypto‑sensitive stocks like MicroStrategy (MSTR), Mara Holdings (MARA) and Coinbase (COIN) are trading higher in pre‑market dealings. ^[28]
Nasdaq’s pre‑market most‑active list includes the iShares Bitcoin Trust (IBIT) and iShares Ethereum Trust (ETHA), both trading above recent lows and seeing heavy volume. ^[29]

The crypto bounce doesn’t change the underlying volatility of the space, but on a quiet macro Monday it’s helping to support broader risk appetite, particularly in high‑beta tech, fintech and AI‑adjacent names.

5. Novo Nordisk’s Alzheimer’s miss rattles healthcare and the GLP‑1 trade

One of the most important single‑stock stories today comes from Novo Nordisk, the Danish pharmaceutical group behind blockbuster weight‑loss drugs Ozempic and Wegovy.

Novo reported that late‑stage Alzheimer’s trials using semaglutide (the active ingredient in its GLP‑1 drugs) did not demonstrate a statistically significant slowing of cognitive decline, even though they showed improvements in certain biomarkers. ^[30]
Analysts had been divided on the odds of success, but the result still disappointed investors hoping for a multi‑disease GLP‑1 “wonder drug” narrative. ^[31]
Novo Nordisk’s U.S.-listed shares (NVO) are down more than 10% in pre‑market trading, making it one of the biggest early decliners and a major contributor to healthcare sector chatter this morning. ^[32]
In Copenhagen, the stock also closed sharply lower, with European coverage highlighting the move as one of the day’s big corporate stories. ^[33]

Why it matters for U.S. investors:

GLP‑1 drugs have been a key driver of healthcare and consumer‑staple valuations this year, with ripple effects across everything from insurers to snack makers.
The Alzheimer’s miss doesn’t directly affect the core obesity and diabetes indications that underpin most revenue forecasts, but it reduces optionality around one of the more speculative upside cases.

You can expect biotech, big pharma and obesity‑themed baskets to see elevated volatility around the open as traders recalibrate their expectations.

6. Trade and geopolitics: U.S.–EU tariff talks and Ukraine peace hopes

U.S.–EU trade talks and Big Tech

U.S. officials, including Commerce Secretary Howard Lutnick, are in Europe today for a new round of trade negotiations. Their message: tariff relief on steel and aluminum will likely require some concessions from Brussels on tech regulation.

European officials have downplayed the odds of a first‑day breakthrough, but talks are ongoing. ^[34]
The U.S. is reported to be linking lower tariffs — including Trump‑era steel and aluminum levies and around 15% tariffs on a wide range of EU goods — to a rollback or softening of digital‑rules that affect American tech giants. ^[35]

For markets, this matters because:

It ties together industrial stocks (steel, autos, manufacturing) and mega‑cap tech in a single negotiating package.
Any sign of progress or breakdown could move multi‑national industrials, luxury names and U.S. Big Tech with large European exposure.

Ukraine peace framework and the defense complex

Over the weekend, Washington and Kyiv said they had drafted an “updated and refined peace framework” to end the war with Russia, after criticism that a previous proposal had leaned too far toward Moscow’s demands. ^[36]

Markets have already started to react:

European defense stocks — including BAE Systems, Rheinmetall, Renk and Babcock — fell between roughly 3% and 5%, as investors contemplated what a peace deal could mean for future weapons spending. ^[37]
European natural‑gas prices also dropped to their lowest levels since mid‑2024 on hopes that a resolution could eventually unlock more supply and ease winter fears. ^[38]

For U.S. traders, this mix could mean:

Pressure on defense names and suppliers tied to European contracts.
A tailwind for global cyclicals and broader risk assets if peace prospects continue to improve.

7. Pre‑market most active: AI, leverage, crypto and Novo dominate

Nasdaq’s Pre‑Market Indicator shows the Nasdaq‑100 itself trading higher, with more than 100 million shares already changing hands before the opening bell. Among the most active individual names: ^[39]

TSLL (Direxion Daily TSLA Bull 2X) – A leveraged Tesla ETF, up about $0.66 with more than 10 million shares traded. Its prominence underscores continued speculative interest in high‑beta EV and AI‑linked plays. ^[40]
Novo Nordisk (NVO) – Down roughly $5.10 per share pre‑market on massive volume after the Alzheimer’s trial disappointment. ^[41]
TQQQ (ProShares UltraPro QQQ) – Another leveraged bet on the Nasdaq, up more than $1 pre‑market, capturing the appetite for adding risk into a potential tech rebound. ^[42]
Alphabet (GOOGL) – Up about $12.50 to just over $312 with heavy volume, supported by a flurry of upward earnings‑estimate revisions and ongoing enthusiasm around its Gemini AI models. ^[43]
Nvidia (NVDA) – Trading higher pre‑market as well, with analysts continuing to revise earnings forecasts upward for 2026 and investors treating it as a bellwether for AI infrastructure demand. ^[44]
IBIT & ETHA (iShares Bitcoin & Ethereum Trusts) – Both showing solid pre‑market gains as crypto prices bounce from last week’s lows. ^[45]
NIO (NIO) – Up ahead of its earnings report scheduled for Tuesday, where analysts expect a narrower loss than a year ago as EV deliveries improve. ^[46]
BigBear.ai (BBAI) – Another AI‑themed name trading actively, continuing the pattern of AI‑linked small‑caps responding aggressively to shifts in sentiment. ^[47]

The overall picture: leverage, AI, crypto and event‑driven pharma are where pre‑market traders are concentrating their firepower today.

8. Earnings and options: where volatility is being priced in

Even with a quiet data docket, corporate earnings and the options market promise plenty of stock‑specific action.

Big names reporting this week

Commentary from research providers highlights a packed slate of results over the next few days: ^[48]

Later today (Monday):
- Agilent Technologies, Symbotic, Keysight Technologies, Woodward and Zoom are among notable companies expected to report after the close. ^[49]
Tuesday, Nov. 25:
- Analog Devices (ADI) – key read‑through on chip demand and industrial/auto exposure.
- Alibaba (BABA) – update on Chinese consumer spending and AI investments.
- Best Buy (BBY) – insight into U.S. electronics demand ahead of Black Friday.
- NIO (NIO) – EV growth and margin trends in China.
- J.M. Smucker (SJM) – consumer staples and pricing power.
- Kohl’s (KSS), Abercrombie & Fitch (ANF), Dick’s Sporting Goods (DKS) – U.S. retail and holiday‑season positioning.
- HP Inc. (HPQ) – PC and printer demand, reported after the bell. ^[50]
Wednesday:
- Li Auto (LI) and other EV names, plus ongoing retail and tech earnings. ^[51]

Options market is braced for big moves

Options‑volatility screens show the market is pricing double‑digit percentage swings in several of these stocks around earnings: ^[52]

Weekly options on ADI and Alibaba imply moves of about 7–8%.
Best Buy, Abercrombie & Fitch and Dick’s Sporting Goods have implied moves around 10–14%, reflecting uncertainty around consumer demand and holiday guidance.
Kohl’s stands out with options pricing in a mid‑teens percentage move, signaling elevated event risk.
HP Inc. and J.M. Smucker are also priced for sizeable reactions in the mid‑single to high‑single digits.

For traders, this means stock‑specific volatility could be significant even if the indexes themselves remain relatively calm into Thanksgiving.

9. How to read today’s market setup

Going into the open, here’s the tug‑of‑war shaping the U.S. stock market on November 24, 2025:

Supportive forces

Rate‑cut optimism: Fed expectations have flipped decisively toward another cut in December, boosting long‑duration tech, growth stocks and speculative areas like AI and crypto. ^[53]
Crypto rebound & AI enthusiasm: Bitcoin’s recovery and strong pre‑market gains in Alphabet, Nvidia and other AI‑linked names are helping to stabilize risk sentiment after earlier “bubble” fears. ^[54]
Peace hopes and lower gas prices: Signs of progress on a Ukraine peace framework and lower European gas prices reduce some tail risks for global growth. ^[55]

Headwinds

November drawdown: Despite today’s bounce, the S&P 500, Nasdaq and Dow are still significantly lower on the month, and valuations in AI and mega‑cap tech remain elevated by historical standards. ^[56]
Data uncertainty: With GDP estimates canceled and several key reports delayed, both the Fed and investors are operating with less information than usual heading into a critical policy meeting. ^[57]
Policy and trade risks: U.S.–EU tariff negotiations, lingering inflation concerns and mixed Fed communication could quickly dent today’s optimism if headlines turn negative. ^[58]

For long‑term investors, today may feel like another chapter in a familiar 2025 story: AI‑and‑rate‑cut hopes battling valuation worries and patchy macro data. For short‑term traders, the combination of a quiet economic calendar, a busy earnings slate and a holiday‑thinned week sets the stage for sharp, headline‑driven moves — especially in the most active pre‑market names highlighted above.

As always, this overview is for information, not investment advice. Anyone considering trades today should weigh these narratives against their own risk tolerance, time horizon and independent research.

🚀 TECH-AKTIEN RALLY - ERST DER ANFANG⁉️💥 NOVO NORDISK 💥 Bitcoin Tesla AMD Nvidia Ethereum Trump